Latest Teijin Limited News & Updates

See the latest news and media coverage for Teijin. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Teijin Limited (Teijin)

Global materials and healthcare technology group

teijin.com
Headquarters
Chiyoda-ku, Japan
Company type
Public company
Number of employees
10,000+
Industry
Specialty Chemicals

Last updated

Latest news about Teijin Limited (Teijin)

In short: Teijin divested its North American automotive and pharmaceutical assets while recording impairment losses and revising earnings forecasts.

Company announcements

Teijin

Teijin corrects previous notice on share disposal

The performance share unit disposal was adjusted from 100,775 to 102,484 shares and from 3 to 14 corporate officers.

Unlock all announcements with a

Media coverage

Nikkei

Teijin sells part of pharmaceutical business to LTL Pharma, including 7 products such as gout drug

Teijin announced on the 17th that it will sell part of its pharmaceutical business to LTL Pharma (Shinjuku, Tokyo). The target is the rights to manufacture and sell seven products including a gout drug, and the sale price is undisclosed. The company has already factored this into its earnings forecast for the fiscal year ending March 2027. Teijin is proceeding with restructuring of pharmaceuticals other than rare diseases by selling them off. The pharmaceutical business is handled by Teijin Pharma (Chiyoda, Tokyo), a subsidiary of Teijin. Among the products to be sold is the gout drug 'Febu...' which previously drove performance with annual sales of about 39 billion yen in Japan.

Unlock all articles with a

Never miss news about Teijin

Track Teijin and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Teijin competitors & trending companies

Browse news for competitors to Teijin and other trending companies.